Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

June 24, 2021, 4:00pm – 6:00pm | New York Genome Center

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, June 24, 2021
4pm – 6pm


Disease Spotlight & Research Roundtable

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

Hepatoblastoma is the most common liver neoplasm in children and accounts for 1% of all childhood malignancies. Over the last decade, the incidence of Hepatoblastoma has nearly doubled, faster than any other childhood cancer, however in this time we have gained little ground in understanding the molecular characteristics that drive the disease. The five-year survival for Hepatoblastoma is estimated at 60-70%, one of the lowest survival rates for childhood cancer, demanding translational studies to improve our understanding of the disease and enable the development of targeted and more effective clinical therapies.

During this VRCC Roundtable focused on Hepatoblastoma, we will hear from a panel of experts and discuss our current understanding of the disease, advances being made in treatment and research, studies needed to improve patient care, and how we might be able to work together to move to field forward.



Robert E. Schwartz, MD, PhD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medicine


Allison O’Neill, MD
Clinical Director, Solid Tumor Center
Director of Medical Therapies, Liver Tumor CenterSenior Physician
Dana-Farber/Boston Children’s Cancer and Blood Disorders CenterAssistant Professor of Pediatrics
Harvard Medical School


Dolores López-Terrada, MD, PhD
Professor of Pathology and Pediatrics
Baylor College of Medicine
Division Chief, Genomic Medicine
Texas Children’s Hospital Department of Pathology


Logan G. Spector, PhD
Suzanne Holmes Hodder Chair in Pediatric Cancer
Research Director, Division of Epidemiology/Clinical Research
Department of Pediatrics
University of Minnesota


Eiso Hiyama, MD, PhD
Professor, Department of Pediatric Surgery
Hiroshima University HospitalDirector, Natural Science Center for Basic Research and Development (N-BARD)
Hiroshima University


Shauna L. Houlihan, PhD
Associate Director of Liver Research
Englander Institute for Precision Medicine
Weill Cornell MedicineScientific Director, Very Rare Cancer Consortium
New York Genome Center


James I. Geller, MD
Director – Liver, Kidney and Retinoblastoma Programs, Cancer and Blood Diseases Institute
Director, Advanced Cancer Therapy Network, Cancer and Blood Disease Institute
Director, Pilot Translational Core Grant Program, Center for Clinical and Translational Science and Training
Professor, UC Department of Pediatrics
Cincinnati Children’s Hospital Medical Center




Any questions on this event, contact